StockrabitBrowse analysts
Analyst questions

Amit Kadam

Canara Mutual Funds
AJANTPHARM

Ajanta Pharma Limited

All company calls
Ajanta Pharma Limited CC-Jun25.pdf
28 Jul 2025
Open call
  1. Hi, sir. Sir, somewhere in the middle of the call, you mentioned about some comments on the cardiac division, that about why our growth rate is lower than the IPM. I think you referred to some pricing related thing. Can you just elaborate on that particular part, why the division growth was lower than IPM? That's it. Thanks.

    Read in transcript
  2. Any specific category of products or any prices in the market, which led to that or something?

    Read in transcript
  3. And according to you, it will take more than 2 odd quarters, 2 to 4 quarters is what you have assumed, that means this would resume or maybe start beating the IPM, maybe in FY...

    Read in transcript
+2 more questions in this call